Last updated on November 2015

A011202: Randomized Phase III Trial Comparing Axillary Lymph node Dissection To Axillary radiation In Breast Cancer Patients (cT1-3N1) Who Have positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Breast Cancer
  • Gender: Male or Female

Eligibility Criteria:

  • Must be T1-3 N1 M0 and have Neoadjuvant Chemotherapy
  • Surgery Intra-operative positive SLN or Positive SLN on Final Pathology

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.